<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Gastroenterol</journal-id><journal-id journal-id-type="iso-abbrev">J Clin Gastroenterol</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Journal of clinical gastroenterology</journal-title></journal-title-group><issn pub-type="ppub">0192-0790</issn><issn pub-type="epub">1539-2031</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12236440</article-id><article-id pub-id-type="pmcid-ver">PMC12236440.1</article-id><article-id pub-id-type="pmcaid">12236440</article-id><article-id pub-id-type="pmcaiid">12236440</article-id><article-id pub-id-type="manuscript-id">NIHMS2081489</article-id><article-id pub-id-type="pmid">40622248</article-id><article-id pub-id-type="doi">10.1097/MCG.0000000000002205</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2081489</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2081489</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Trends in substance use disorder among hospitalized patients with inflammatory bowel disease: an 11-year nationwide study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Zheng</surname><given-names initials="M">Melanie</given-names></name><degrees>MD, MHS</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>DeDecker</surname><given-names initials="L">Lauren</given-names></name><degrees>MD</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="PH">Po-Hung</given-names></name><degrees>MD PhD</degrees><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Limketkai</surname><given-names initials="BN">Berkeley N.</given-names></name><degrees>MD PhD</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland</aff><aff id="A2"><label>2</label>Vatche &amp; Tamar Manoukian Division of Digestive Diseases, UCLA School of Medicine, Los Angeles, California</aff><aff id="A3"><label>3</label>Division of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland</aff><aff id="A4"><label>4</label>Division of Addiction Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland</aff><author-notes><fn fn-type="equal" id="FN1"><label>*</label><p id="P1">Drs. Po-Hung Chen and Berkeley Limketkai contributed equally to this manuscript.</p></fn><corresp id="CR1"><bold>Correspondence:</bold> Po-Hung (Victor) Chen, 1830 E. Monument Street, Suite 429, Baltimore, Maryland 21287, <email>pchen37@jhmi.edu</email>, Fax: 410-550-7861</corresp></author-notes><pub-date pub-type="epub"><day>02</day><month>7</month><year>2025</year></pub-date><issue-id pub-id-type="pmc-issue-id">492429</issue-id><elocation-id>10.1097/MCG.0000000000002205</elocation-id><pub-history><event event-type="nihms-submitted"><date><day>03</day><month>06</month><year>2025</year></date></event><event event-type="pmc-release"><date><day>02</day><month>07</month><year>2026</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-07-09 10:25:22.923"><day>09</day><month>07</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2081489.pdf"/><abstract id="ABS1"><sec id="S1"><title>Goals:</title><p id="P2">We described the temporal trend of substance use disorder (SUD) and SUD subtypes among patients hospitalized with inflammatory bowel disease (IBD), accounting for readmissions within the calendar year.</p></sec><sec id="S2"><title>Background:</title><p id="P3">One in six patients with IBD is estimated to have a concomitant SUD. SUD has had mounting morbidity and mortality rates since 2010 and has been shown to adversely affect IBD activity.</p></sec><sec id="S3"><title>Study:</title><p id="P4">We performed a retrospective analysis of patients hospitalized at least once with IBD from 2010 through 2020 using the Nationwide Readmissions Database. Multivariable logistic regression analysis evaluated associations between SUD and age, sex, insurance type, income for ZIP Code, and geographic region.</p></sec><sec id="S4"><title>Results:</title><p id="P5">Of 2,532,450 patients hospitalized with IBD, 26.5% and 17.0% involved SUD in Crohn&#8217;s disease (CD) and ulcerative colitis (UC), respectively. Between 2010&#8211;2020, the prevalence of patients with SUD increased from 23.8% to 27.9% in CD (P<sub>trend</sub>&lt;0.001) and 14.2% to 19.4% in UC (P<sub>trend</sub>&lt;0.001). Rates of alcohol, opioid, and cannabis use disorders increased (P<sub>trend</sub>&lt;0.001 for all). Patients with SUD were more likely to be male (CD: OR 1.26, 95% CI [1.24, 1.27]; UC: 1.34, [1.31, 1.36]), have Medicaid insurance compared to Medicare (CD: 1.59, [1.55, 1.63]; UC: 1.84, [1.78, 1.90]), and be in a lower income quartile (lowest to highest quartile, CD: 1.54, [1.51, 1.58]; UC: 1.56, [1.52, 1.61]).</p></sec><sec id="S5"><title>Conclusions:</title><p id="P6">SUD among IBD patients continued to increase over time, with the predominant substances used shifting from alcohol to opioids and cannabis. Rates of SUD among patients hospitalized with CD were consistently higher than those with UC or with non-IBD-related hospitalizations.</p></sec></abstract><kwd-group><kwd>Substance use disorder</kwd><kwd>alcohol use</kwd><kwd>cannabis use</kwd><kwd>opioid use</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-exception-type</meta-name><meta-value>EMBARGO</meta-value></custom-meta><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>4</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>no</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>